Skip to main content

Table 3 Enriched functional group in GCMN

From: Human giant congenital melanocytic nevus exhibits potential proteomic alterations leading to melanotumorigenesis

Functional group

Group Genes

GOID

% Genes 1

p-Value 2

p-Value/B 3

Cell cycle

ANXA1|SFN|YWHAB|YWHAE|YWHAG|YWHAQ|YWHAZ

KEGG:04110

5.0

9.00E-07

4.77E-05

Phospholipase inhibitor activity

ANXA1|ANXA2|ANXA5|ARHGDIA|ATP5B|KRT1

GO:0004859

27.3

3.17E-06

1.68E-04

Melanosome

ANXA1|ANXA2|ANXA5|ATP5B|CLIC1|CTSD|FASN|HRNR|HSP90AA1|HSP90AB1|HSPA1B|HSPA8|HSPB1|KRT1|PDIA3|RAC1|SFN|YWHAB|YWHAE|YWHAG|YWHAZ

GO:004247

12.8

4.09E-16

2.17E-14

Neurotrophin signaling pathway

ACTB|ARHGDIA|CAPZA1|CAPZB|CDC42|HSPB1|MYLK|RAC1|SFN|YWHAB|YWHAE|YWHAG|YWHAQ|YWHAZ

KEGG:04722

6.1

2.36E-09

1.25E-07

Downregulated of MTA-3 in ER-negative breast tumors

ADH1B|ALDOA|CTSD|ECH1|HSPB1|PHGDH|RYR3

BioCarta:204

28.6

4.94E-08

2.62E-06

Glycolysis/Gluconeogenesis

ADH1B|ALDOA|ECH1|FASN

KEGG:00010

4.7

7.23E-04

0.038

  1. 1% of associated genes identified in our results/total known genes involved in the function or pathway, 2Term p-Value, 3Term p-Value with Bonferroni correction.